Wir sind mit live! Mehr erfahren
1.004,84 USD
+6,20
0,62 %
Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT
Vor Börsenbeginn
Nachbörslich
1.004,84
0,00
0 %
1 Tag
0,62 %
5 Tage
5,78 %
1 Monat
13,25 %
3 Monate
19,44 %
6 Monate
15,85 %
Seit Jahresbeginn
22,03 %
1 Jahr
29,58 %
5 Jahre
400,42 %
10 Jahre
525,48 %
 

Profil: McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Mitarbeiter: 43.000

Nachrichten

Positiv
Neutral
Negativ
Stimmung 3 Monate
Positiv 62,3 %
Neutral 29,9 %
Negativ 7,8 %
Neutral
Benzinga
gestern
Jim Cramer: This Health Care Stock Is A ‘Winner', X-Energy Is ‘Losing Too Much Money'
On CNBC's “Mad Money Lightning Round,” Jim Cramer said McKesson Corporation (NYSE:MCK) is a “winner” and it will go much higher. “It is exactly what you buy in this environment," he added.
Jim Cramer: This Health Care Stock Is A ‘Winner', X-Energy Is ‘Losing Too Much Money'
Neutral
Zacks Investment Research
vorgestern
McKesson (MCK) Ascends While Market Falls: Some Facts to Note
McKesson (MCK) reached $976.57 at the closing of the latest trading day, reflecting a +1.53% change compared to its last close.
McKesson (MCK) Ascends While Market Falls: Some Facts to Note
Positiv
Zacks Investment Research
vor 3 Tagen
McKesson (MCK) is a Top-Ranked Value Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
McKesson (MCK) is a Top-Ranked Value Stock: Should You Buy?
Positiv
Zacks Investment Research
vor 7 Tagen
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
Positiv
Zacks Investment Research
vor 8 Tagen
Here's Why McKesson (MCK) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why McKesson (MCK) is a Strong Growth Stock
Positiv
Zacks Investment Research
vor 8 Tagen
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Here is how McKesson (MCK) and Avantor, Inc. (AVTR) have performed compared to their sector so far this year.
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Neutral
Zacks Investment Research
vor 8 Tagen
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
Negativ
Zacks Investment Research
vor 9 Tagen
Here's Why McKesson (MCK) Fell More Than Broader Market
In the closing of the recent trading day, McKesson (MCK) stood at $910.33, denoting a -1.23% move from the preceding trading day.
Here's Why McKesson (MCK) Fell More Than Broader Market
Positiv
Zacks Investment Research
vor 9 Tagen
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"
McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"
Positiv
Zacks Investment Research
vor 9 Tagen
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
Kursdiagramme mit Lightweight Charts™ umgesetzt